Related Experiment Videos
High sodium intake increases platelet aggregation in normal females
I F Gow1, P L Padfield, M Reid
1Department of Medicine, Western General Hospital, Edinburgh, Scotland.
Summary
High sodium intake increases platelet aggregation in women, which is linked to lower serotonin levels. Ketanserin partially reversed this effect, suggesting a role for serotonin in salt-induced platelet activation.
Area of Science:
- Cardiovascular Science
- Hematology
- Nutrition Science
Background:
- Platelet activation and aggregation are crucial in vascular disease development.
- Dietary factors, such as sodium intake, may influence platelet function.
- Serotonin plays a role in platelet aggregation and vascular tone.
Purpose of the Study:
- To investigate the impact of varying sodium intake on platelet aggregation and plasma serotonin levels in normal females.
- To explore the correlation between sodium status, serotonin concentration, and platelet aggregation.
- To assess the effect of ketanserin and saralasin on platelet aggregation during high sodium intake.
Main Methods:
- 12 healthy female volunteers consumed diets with 10 or 200 mmol/day sodium for 5 days.
- Platelet-rich plasma (PRP) was incubated with adenosine diphosphate (ADP) to induce aggregation.
- PRP was pre-incubated with ketanserin or saralasin to evaluate their effects on aggregation.
Main Results:
- High sodium intake significantly increased platelet aggregation induced by ADP.
- Salt-loading led to a significant decrease in plasma serotonin concentration.
- A significant negative correlation was observed between serotonin levels and ADP-induced platelet aggregation.
- Ketanserin reduced platelet aggregation during high sodium intake, while saralasin had no effect on aggregation.
Conclusions:
- High sodium intake enhances in vitro platelet aggregation in normal females, an effect partially mitigated by ketanserin.
- Changes in sodium status significantly alter platelet count and plasma serotonin levels.
- Platelet aggregation is inversely proportional to plasma serotonin concentration in this cohort.